Abstract
The patterns of lupus nephritis lesions differ from patient to patient and in the same patient from glomerulus to glomerulus. Despite this diversity, considerable progress has been made in treatment and in improving prognosis. Ongoing investigations presage the development of new therapeutic approaches, including the use of biologic and pharmacologic immunomodulation.